VBI Vaccines
VBIV
$0.58
Share price
2.30%
Change (1 day)
-79.84%
Change (1 year)
Categories
P/S ratio for VBI Vaccines (VBIV)
P/S ratio as of May 2024 (TTM): 1.91
According to VBI Vaccines 's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 1.90793. At the end of 2023 the company had a P/S ratio of 1.88.
P/S ratio history for VBI Vaccines from 2008 to 2023
PS ratio at the end of each year
| Year | P/S ratio | Change |
|---|---|---|
| 2023 | 1.88 | -97.99% |
| 2022 | 93.3 | -90.22% |
| 2021 | 954 | 52.09% |
| 2020 | 627 | 466.43% |
| 2019 | 111 | 138.58% |
| 2018 | 46.4 | -85.26% |
| 2017 | 315 | 53.04% |
| 2016 | 206 | -79.54% |
| 2015 | > 1000 | |
| 2014 | N/A | |
| 2013 | N/A | |
| 2012 | N/A | |
| 2011 | N/A | |
| 2010 | N/A | |
| 2009 | N/A | |
| 2008 | N/A |
P/S ratio for similar companies or competitors
| Company | P/S ratio | P/S ratio differencediff. | Country |
|---|---|---|---|
 Onconova Therapeutics ONTX | 92.5 | 4,748.11% | 🇺🇸 USA |
 Curis CRIS | 9.71 | 408.87% | 🇺🇸 USA |
 Myriad Genetics MYGN | 2.31 | 21.01% | 🇺🇸 USA |